000 | 02000 a2200541 4500 | ||
---|---|---|---|
005 | 20250518050636.0 | ||
264 | 0 | _c20201116 | |
008 | 202011s 0 0 eng d | ||
022 | _a1865-7265 | ||
024 | 7 |
_a10.1007/s12328-019-01018-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFujimori, Naoyuki | |
245 | 0 | 0 |
_aLong-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus. _h[electronic resource] |
260 |
_bClinical journal of gastroenterology _cFeb 2020 |
||
300 |
_a83-89 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAlanine Transaminase _xmetabolism |
650 | 0 | 4 |
_aAspartate Aminotransferases _xmetabolism |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 |
_aMetformin _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xcomplications |
650 | 0 | 4 |
_aSodium-Glucose Transporter 2 Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aSorbitol _xanalogs & derivatives |
650 | 0 | 4 |
_aSulfonylurea Compounds _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTanaka, Naoki | |
700 | 1 | _aKimura, Takefumi | |
700 | 1 | _aSano, Kenji | |
700 | 1 | _aHoriuchi, Akira | |
700 | 1 | _aKato, Naoyuki | |
700 | 1 | _aTakahashi, Yoshiyuki | |
700 | 1 | _aKuribayashi, Naoya | |
700 | 1 | _aSugiura, Ayumi | |
700 | 1 | _aYamazaki, Tomoo | |
700 | 1 | _aJoshita, Satoru | |
700 | 1 | _aUmemura, Takeji | |
700 | 1 | _aMatsumoto, Akihiro | |
700 | 1 | _aTanaka, Eiji | |
773 | 0 |
_tClinical journal of gastroenterology _gvol. 13 _gno. 1 _gp. 83-89 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12328-019-01018-1 _zAvailable from publisher's website |
999 |
_c29888629 _d29888629 |